ClinicalTrials.Veeva

Menu

The Characteristics and Role of Mucosal Microbiome After Treatment of Clostridioides Difficile Infection

Mayo Clinic logo

Mayo Clinic

Status

Completed

Conditions

Clostridioides Difficile Infection

Study type

Observational

Funder types

Other

Identifiers

NCT04668014
19-005228

Details and patient eligibility

About

This research is being done to study the ability of C. difficile to colonize the colonic mucosa of individuals with no prior history of C. difficile infection.

Full description

The ability of C. difficile to colonize the mucosa of the colon will be studied in healthy individuals with no history of C. difficile infection who are undergoing colonoscopy for colon cancer/polyp screening purposes.

Enrollment

20 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults aged 18 and over
  • No history of C. difficile infection
  • Undergoing clinically indicated colonoscopy for colon cancer screening or colon polyp surveillance purposes in the absence of active GI symptoms.

Exclusion criteria

  • Known active pregnancy
  • Other known active gastrointestinal infectious process
  • Inflammatory gastrointestinal conditions (microscopic colitis, inflammatory bowel disease, Celiac disease)
  • Vulnerable adults
  • Any other disease(s), condition(s) or habit(s) that would interfere with completion of study, or in the judgment of the investigator would potentially interfere with compliance to this study or would adversely affect study outcomes

Trial contacts and locations

1

Loading...

Central trial contact

Heather Lekatz

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems